» Articles » PMID: 35946877

Probiotics in Experimental Ulcerative Colitis: Mast Cell Density and Neuronal Hypertrophy

Overview
Publisher Aves
Specialty Gastroenterology
Date 2022 Aug 10
PMID 35946877
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Probiotics such as Lactobacillus and Bifidobacterium are among the supportive treatment methods to achieve effective results in ulcerative colitis. This study was established to investigate the effect of probiotics in experimental ulcerative colitis and to detect changes in mast cell and neuronal structures in this treatment method.

Methods: A total of 48 adult male rats were used to study the effects of probiotics on ulcerative colitis. The animals were divided into 6 groups as control, experimental colitis, and four probiotic protective groups. Three different bacterial strains were administered to the protective groups individually and in combination by gavage. PGP 9.5 antibody and mast cell tryptase were used for the detection of neuronal structures and mast cells. The number of Schwann cells and ganglia, size measurements of ganglia, and density of mast cells were evaluated.

Results: Compared to the control, an increase in the number of mast cells was detected in all groups. Especially the increase in the num- ber of mast cells was found to be statistically significant in combined probiotic administration. In the detection of neuronal structures, a significant increase in the number of Schwann cells and ganglia was detected in groups where probiotics were administered combined and individually.

Conclusion: These results suggest that probiotics may play a role in the supporting effect of increasing the number of mast cells and neuronal structures, protecting the intestinal wall. We think that more specific and detailed studies should be conducted to evaluate the protective/therapeutic effect of probiotics in future studies.

Citing Articles

Recent updates on correlation between reactive oxygen species and synbiotics for effective management of ulcerative colitis.

Ashique S, Mishra N, Garg A, Sibuh B, Taneja P, Rai G Front Nutr. 2023; 10:1126579.

PMID: 37545572 PMC: 10400011. DOI: 10.3389/fnut.2023.1126579.

References
1.
Rijnierse A, Koster A, Nijkamp F, Kraneveld A . Critical role for mast cells in the pathogenesis of 2,4-dinitrobenzene-induced murine colonic hypersensitivity reaction. J Immunol. 2006; 176(7):4375-84. DOI: 10.4049/jimmunol.176.7.4375. View

2.
Douaiher J, Succar J, Lancerotto L, Gurish M, Orgill D, Hamilton M . Development of mast cells and importance of their tryptase and chymase serine proteases in inflammation and wound healing. Adv Immunol. 2014; 122:211-52. PMC: 4115062. DOI: 10.1016/B978-0-12-800267-4.00006-7. View

3.
Rigoni A, Bongiovanni L, Burocchi A, Sangaletti S, Danelli L, Guarnotta C . Mast Cells Infiltrating Inflamed or Transformed Gut Alternatively Sustain Mucosal Healing or Tumor Growth. Cancer Res. 2015; 75(18):3760-70. DOI: 10.1158/0008-5472.CAN-14-3767. View

4.
Bron P, Kleerebezem M, Brummer R, Cani P, Mercenier A, Macdonald T . Can probiotics modulate human disease by impacting intestinal barrier function?. Br J Nutr. 2017; 117(1):93-107. PMC: 5297585. DOI: 10.1017/S0007114516004037. View

5.
Bauer O, Razin E . Mast Cell-Nerve Interactions. News Physiol Sci. 2001; 15:213-218. DOI: 10.1152/physiologyonline.2000.15.5.213. View